This table shows the serotypes covered by the current pneumococcal conjugate vaccine products and the three additional products that are in the development pipeline. 

This brief gives an outline of the current rotavirus products and upcoming products.

The VIEW-hub report displays data and figures on the introduction, use, and coverage status of pneumococcal, rotavirus, and inactivated polio vaccines both globally and in the 73 Gavi countries as of June 2020.

This document summarizes the files in necessary to calculate global, regional, and national Hib and pneumococcal disease burden as published in the Lancet G

These files contain the data used to calculate global, regional, and national Hib and pneumococcal disease burden as published in the Lancet Global Health (Wahl, B, et al., 2018).

The VIEW-hub report displays data and figures on the introduction, use, and coverage status of pneumococcal, rotavirus, and inactivated polio vaccines both globally and in the 73 Gavi countries as of March 2020.

The VIEW-hub report displays data and figures on the introduction, use, and coverage status of pneumococcal, rotavirus, and inactivated polio vaccines both globally and in the 73 Gavi countries as of December 2020.

The VIEW-hub report displays data and figures on the introduction, use, and coverage status of pneumococcal, rotavirus, and inactivated polio vaccines both globally and in the 73 Gavi countries as of September 2019.

The VIEW-hub report displays data and figures on the introduction, use, and coverage status of pneumococcal, rotavirus, and inactivated polio vaccines both globally and in the 73 Gavi countries as of June 2019.

The VIEW-hub report displays data and figures on the introduction, use, and coverage status of pneumococcal, rotavirus, and inactivated polio vaccines both globally and in the 73 Gavi countries as of March 2019.